Kezar Life Sciences, Inc. Common Stock (KZR) is a publicly traded Healthcare sector company. As of May 21, 2026, KZR trades at $7.29 with a market cap of $53.86M and a P/E ratio of -0.95. KZR moved -0.82% today. Year to date, KZR is +14.80%; over the trailing twelve months it is +76.94%. Its 52-week range spans $3.53 to $9.18. Analyst consensus is neutral with an average price target of $7.00. Rallies surfaces KZR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kezar Life Sciences, Inc. Common Stock (KZR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KZR moved -0.82% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $7.29 |
| Market Cap | $53.86M |
| P/E Ratio | -0.95 |
| EPS | $-7.66 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.18 |
| 52-Week Low | $3.53 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-56.03M |
| Gross Margin | 0.00% |
1 analysts cover KZR: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.00.